Sign in

CIK 0001488039 · Non-accelerated filer<br>Smaller reporting company

ATOSSA THERAPEUTICS, INC.

Sign in to watch
Ticker
ATOS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
264753208
Phone
206.588.0256
Business address
1448 NW MARKET STREET, SUITE 500, SEATTLE, WA, 98107
Former names
ATOSSA GENETICS INC
  1. SC 13G Stake Amended Statement of Ownership
  2. SC 13G/A Stake Amended Statement of Ownership
  3. SC 13G Stake Amended Statement of Ownership
  4. 424B3 Offering Prospectus
  5. 8-K Event Material agreement
  6. SC 13G Stake Amended Statement of Ownership
  7. 424B5 Offering Prospectus
  8. 8-K Event Material agreement
  9. SC 13G Stake Amended Statement of Ownership
  10. 8-K Event Material agreement
  11. 424B3 Offering Prospectus
  12. EFFECT Other Notice of Effectiveness
  13. 8-K Event Exhibits
  14. CORRESP Other Correspondence Between Filers and SEC Staff
  15. CORRESP Other Correspondence Between Filers and SEC Staff
  16. S-1/A Offering Registration Statement
  17. 8-K Event Other events
  18. UPLOAD Other SEC-generated Letter
  19. S-1 Offering Registration Statement
  20. 10-Q Report Quarterly Report

Page 12 of 33 · 643 filings